Keyword: Pfizer

News

Optimer Shares Rise After Report Names Glaxo, Cubist as Potential Buyers

03.04.2013 - Shares of Optimer Pharmaceuticals rose as much as 24% after a Bloomberg report said GlaxoSmithKline and Cubist Pharmaceuticals were among those interested in buying the antibiotic...

News

Novartis Loses Landmark India Cancer Drug Patent Case

02.04.2013 - India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...

News

Pfizer Fails to End Lawsuit Over Bextra, Celebrex Safety

29.03.2013 - Pfizer has failed to persuade a federal judge to dismiss a shareholder lawsuit accusing the company of fraudulently misrepresenting the safety of its Celebrex and Bextra pain...

News

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

29.03.2013 - The United States is striving to find an appropriate balance in Asia-Pacific free trade talks between providing strong patent and data protections for U.S. drug manufacturers and...

News

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

27.03.2013 - Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...

News

Pfizer Gets Celebrex Patent Extension

05.03.2013 - U.S. regulators granted Pfizer a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on...

News

Generics Brought Down Common Drug Prices in 2012

05.03.2013 - Cheaper generic drugs in 2012 brought down spending on treatments for common diseases like high cholesterol for the first time in 20 years, according to a report from the largest...

News

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

27.02.2013 - GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor...